Skip to Main Content

Author Details

Daiki Ueno
Institute of Urologic Oncology, University of California Los Angeles
2012
21
10
PMIDPaper TitleJournal TitlePublished Year
37255402FH Variant Pathogenicity Promotes Purine Salvage Pathway Dependence in Kidney Cancer.Cancer Discov2023
36128328Targeting Krebs-cycle-deficient renal cell carcinoma with Poly ADP-ribose polymerase inhibitors and low-dose alkylating chemotherapy.Oncotarget2022
35874919Single-cell transcriptomes underscore genetically distinct tumor characteristics and microenvironment for hereditary kidney cancers.iScience2022
32972793Distinguishing Benign Renal Tumors with an Oncocytic Gene Expression (ONEX) Classifier.Eur Urol2021
32471985Ovarian BDNF promotes survival, migration, and attachment of tumor precursors originated from p53 mutant fallopian tube epithelial cells.Oncogenesis2020
30711333Glutamine and the Tumor Immune Microenvironment.Eur Urol2019
31175180Inhibition of Heat Shock Protein 90 suppresses TWIST1 Transcription.Mol Pharmacol2019
29760223Genomic Heterogeneity and the Small Renal Mass.Clin Cancer Res2018
30013182Krebs-cycle-deficient hereditary cancer syndromes are defined by defects in homologous-recombination DNA repair.Nat Genet2018
29464355FDG PET/CT after first molecular targeted therapy predicts survival of patients with renal cell carcinoma.Cancer Chemother Pharmacol2018
29661484The Cell Cycle Progression Score: Unclear Role in Renal Cell Carcinoma.Eur Urol2018
29516208Time-dependent change in relapse sites of renal cell carcinoma after curative surgery.Clin Exp Metastasis2018
27572059Comparison of the performance of experienced and novice surgeons: measurement of gripping force during laparoscopic surgery performed on pigs using forceps with pressure sensors.Surg Endosc2017
28331985One-month assessment of renal cell carcinoma treated by everolimus using FDG PET/CT predicts progression-free and overall survival.Cancer Chemother Pharmacol2017
28068944The acceleration of glucose accumulation in renal cell carcinoma assessed by FDG PET/CT demonstrated acquisition of resistance to tyrosine kinase inhibitor therapy.BMC Cancer2017
27039323Comparison of 11C-4DST and 18F-FDG PET/CT imaging for advanced renal cell carcinoma: preliminary study.Abdom Radiol (NY)2016
26857818FDG PET/CT as a prognostic biomarker in the era of molecular-targeting therapies: max SUVmax predicts survival of patients with advanced renal cell carcinoma.BMC Cancer2016
25721949Validation of a patient-specific simulator for laparoscopic renal surgery.Int J Urol2015
24885730The early response of renal cell carcinoma to tyrosine kinase inhibitors evaluated by FDG PET/CT was not influenced by metastatic organ.BMC Cancer2014
24927795Prediction of open urinary tract in laparoscopic partial nephrectomy by virtual resection plane visualization.BMC Urol2014
22551397Early assessment by FDG-PET/CT of patients with advanced renal cell carcinoma treated with tyrosine kinase inhibitors is predictive of disease course.BMC Cancer2012
  • 1 - 21 of 21

Recommended Authors

Dibson D Gondim
University of Louisville
Career Start Year 2012
Number of shared co-authors 0
Johannes C van der Mijn
New York Presbyterian Hospital
Career Start Year 2012
Number of shared co-authors 0
Meenu Jain
Georgia Cancer Center, Augusta University
Career Start Year 2011
Number of shared co-authors 0
Mohammed I Khan
Stanford University
Career Start Year 2011
Number of shared co-authors 1
Alexandra Drakaki
David Geffen School of Medicine at university of california los angeles
Career Start Year 2009
Number of shared co-authors 4
Ana M Molina
Englander Institute for Precision Medicine
Career Start Year 2007
Number of shared co-authors 2
Song Wu
The Third Affiliated Hospital of Shenzhen University (Luohu Hospital Group)
Career Start Year 2006
Number of shared co-authors 1
Roula Albadine
Centre hospitalier de l'Universite de Montreal
Career Start Year 2006
Number of shared co-authors 1
Paul L Crispen
University of Florida
Career Start Year 2005
Number of shared co-authors 1
Pavlos Msaouel
The University of Texas MD Anderson Cancer Center
Career Start Year 2004
Number of shared co-authors 2
Fan Zhang
Huaihe Hospital of Henan University
Career Start Year 2004
Number of shared co-authors 1
Lin Qi
Xiangya Hospital of Central South University
Career Start Year 2003
Number of shared co-authors 0
Toni K Choueiri
Dana-Farber Cancer Institute
Career Start Year 2002
Number of shared co-authors 5
Thai H Ho
Mayo Clinic Arizona
Career Start Year 2002
Number of shared co-authors 1
Jun Hyuk Hong
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 2002
Number of shared co-authors 0
Byong Chang Jeong
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 2001
Number of shared co-authors 0
Brian A Costello
The Mayo Clinic
Career Start Year 2001
Number of shared co-authors 1
Jes??s Garc??a-Donas
HM Hospitales-Centro Integral Oncologico Clara Campal
Career Start Year 2001
Number of shared co-authors 0
Hyun Moo Lee
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 2000
Number of shared co-authors 0
Cheol Kwak
Seoul National University Hospital, Seoul National University College of Medicine
Career Start Year 2000
Number of shared co-authors 0
Rohit Mehra
Michigan Center for Translational Pathology.
Career Start Year 2000
Number of shared co-authors 4
Ithaar H Derweesh
university of california san diego School of Medicine
Career Start Year 2000
Number of shared co-authors 1
Seong Il Seo
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 1999
Number of shared co-authors 0
Surena F Matin
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 1
Ganesh V Raj
University of Texas Southwestern Medical Center at Dallas
Career Start Year 1994
Number of shared co-authors 2
James J Hsieh
Washington University
Career Start Year 1994
Number of shared co-authors 1
Choung-Soo Kim
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 1993
Number of shared co-authors 0
Holger Moch
University Hospital Zurich
Career Start Year 1991
Number of shared co-authors 1
David M Nanus
Sandra and Edward Meyer Cancer Center
Career Start Year 1983
Number of shared co-authors 0
Victor E Reuter
Memorial Sloan Kettering Cancer Center
Career Start Year 1983
Number of shared co-authors 5

Collaborators

Brian Shuch
University of California los angeles
Co-authored papers 10
Shinji Ohtake
Institute of Urologic Oncology, University of California los angeles
Co-authored papers 2
Xun Bao
Wayne State University School of Medicine, Barbara Ann Karmanos Cancer Institute
Co-authored papers 2
Patrick McGillivray
Johns Hopkins University School of Medicine
Co-authored papers 2
Jamil S Syed
Yale School of Medicine
Co-authored papers 2
Ranjini K Sundaram
Yale University
Co-authored papers 2
Paul C Boutros
University of California los angeles
Co-authored papers 2
Ranjit S Bindra
Yale University School of Medicine
Co-authored papers 2
Peter A Humphrey
Yale University School of Medicine
Co-authored papers 2
Adebowale J Adeniran
Yale School of Medicine
Co-authored papers 2
Kevin A Nguyen
Veterans Affairs Palo Alto Healthcare System, Stanford University School of Medicine
Co-authored papers 2
Blake R Wilde
University of California los angeles
Co-authored papers 1
Yuval Kluger
Yale University School of Medicine
Co-authored papers 1
William Marston Linehan
Co-authored papers 1
Jinny van Doorn
Yale University School of Medicine
Co-authored papers 1
Izak Faiena
Columbia University Medical Center
Co-authored papers 1
Neil Mendhiratta
National Cancer Institute, National Institutes of Health
Co-authored papers 1
Rong-Rong Huang
Stomatology Hospital, Zhejiang University School of Medicine
Co-authored papers 1
Edward D Esplin
Invitae Corporation
Co-authored papers 1
Juan C Vasquez
Yale School of Medicine
Co-authored papers 1
Jiayu Liang
institute of urology
Co-authored papers 1
Peter G Schulam
Yale University
Co-authored papers 1
Amrita Sule
Yale University
Co-authored papers 1
Karen Ouyang
Invitae Corporation
Co-authored papers 1
Aydin Pooli
David Geffen School of Medicine, University of California los angeles
Co-authored papers 1
Heather R Christofk
Jonsson Comprehensive Cancer Center, University of California los angeles
Co-authored papers 1
Karla Boyd
Yale University School of Medicine
Co-authored papers 1
Jing Li
Karmanos Cancer Institute, Wayne State University
Co-authored papers 1
Jack Dodson
University of California los angeles
Co-authored papers 1
Hidewaki Nakagawa
RIKEN Center for Integrative Medical Sciences
Co-authored papers 1
Release 1.2